Forward look: Tenth anniversary of the human genome sequence and 21st century postgenomics global health - A close up on Africa and women's health

Current Pharmacogenomics and Personalized Medicine

Volumn 9, Issue 3, 2011, Pages 148-155

  Kamal, Sanaa M ^a   Warnich, Louise ^b   Ferguson, Lynnette R ^c   Srivastava, Sanjeeva ^d   Ray, Sandipan ^d   Avard, Denise ^e   Joly, Yann ^e   le Huynh, Michael ^e   Page, Madeline ^e   Masellis, Mario ^f   Dove, Edward S ^e   Gurwitz, David ^g   Ozdemir, Vural ^e  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c THE UNIVERSITY OF AUCKLAND   (New Zealand)

^d INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g TEL AVIV UNIVERSITY   (Israel)

Author keywords

Africa; Essential diagnostics model list; Essential medicines; Global public health; Pharmacogenomics research funding and development aid; Political determinants of health; Postgenomics personalized medicine; Women's health

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; ESSENTIAL DRUG;

AFRICA; ANTIVIRAL RESISTANCE; DNA POLYMORPHISM; EDITORIAL; EGYPT; HEALTH CARE FACILITY; HEPATITIS C; HUMAN; HUMAN GENOME; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MATERNAL WELFARE; NONHUMAN; NUTRIGENOMICS; PERSONALIZED MEDICINE; PHARMACOGENOMICS; PROTEOMICS; PUBLIC HEALTH; SEX DIFFERENCE; UTERUS MYOMA; WOMEN'S HEALTH;

EID: 80052220455     PISSN: 18756921     EISSN: 18756913     Source Type: Journal    
DOI: 10.2174/187569211796957511     Document Type: Editorial

References (54)

1. WHO. Agenda. Available at: http://www.who.int/about/agenda/en/index.html [Accessed June 29, 2011].
2. Tutu D. My genome. Science 2011; 331: 689.
3. Kickbusch I. The Leavell lecture-the end of public health as we know it: constructing global public health in the 21st century. Public Health 2004; 188(7): 463-469.
4. Kickbusch I. Tackling the political determinants of global health. BMJ 2005; 331(7511): 246-247.
5. National Science Foundation. Office of Cyberinfrastructure. Advisory Committee for Cyberinfrastucture (ACCI) Task Force Reports, 2011. Available from: http://www.nsf.gov/od/oci/taskforces/ [Accessed June 29, 2011].
6. Pang T. Pharmacogenomics and Personalized medicine for the developing world - Too soon or just-in-time? A Personal view from the World Health Organization. Curr Pharmacogenomics Person Med 2009; 7: 149-157.
7. Ozdemir V, Smith C, Bongiovanni K, et al. Policy and dataintensive scientific discovery in the beginning of the 21st century. OMICS 2011; 15(4): 221-225.
8. Ozdemir V, Muljono DH, Pang T, et al. Asia-Pacific Health 2020 and genomics without borders: co-production of knowledge by science and society partnership for global personalized medicine. Curr Pharmacogenomics Person Med 2011; 9(1): 1-5. Available from: http://www.benthamscience.com/cppm/openaccessarticles/cppm9-1/001AF.pdf [Accessed June 29, 2011].
9. Kolker E, Higdon R, Welch D, et al. SPIRE: Systematic protein investigative research environment. J Proteomics 2011 May 13. [Epub ahead of print].
10. Ozdemir V, Husereau D, Hyland S, et al. Personalized medicine beyond genomics: new technologies, global health diplomacy and anticipatory governance. Curr Pharmacogenomics Person Med 2009; 7(4): 225-230. Available from: http://www.benthamscience.com/cppm/openaccessarticles/cppm7-4/001AF.pdf [Accessed June 29, 2011].
11. Zgheib NK, Ghaddar F, Sabra R. Teaching pharmacogenetics in low and middle-income countries: team based learning and lessons learned at the American University of Beirut. Curr Pharmacogenomics Person Med 2011; 9(1): 25-40.
12. Warnich L, Drögemöller BI, Pepper MS, et al. Pharmacogenomics research in South Africa: lessons learned and future opportunities in the rainbow nation. Curr Pharmacogenomics Person Med 2011; 9(3) (in press). Available from: http://www.benthamscience.com/openaccessplus.php?JCode=CPPM [Accessed June 29, 2011].
13. Burton H, Nacul L, Sanderson S. Personalised medicine: lessons from birth defects and single gene disorders. Curr Pharmacogenomics Person Med 2011; 9(2): 80-83. Available from: http://www.benthamscience.com/openaccessplus.php?JCode=CPPM [Accessed June 29, 2011].
14. Khoury MJ.; Muin J. Khoury discusses the future of public health genomics and why it matters for personalized medicine and global health. Curr Pharmacogenomics Person Med 2009; 7(3): 158-163. Available from: http://www.benthamscience.com/cppm/openaccessarticles/cppm7-3/003AF.pdf [Accessed June 29, 2011].
15. Partnership for Maternal, Newborn & Child Health. Countdown to 2015 MNCH Landscape. Press release; available from: http://www.who.int/pmnch/media/press_materials/pr/2010/20100413_countdownmap/en/ [Accessed June 29, 2011].
16. Pang T. Developing medicines in line with global public health needs: the role of the World Health Organization. Cambridge Quarterly of Healthcare Ethics 2011; 20: 290-297.
17. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 2011; 17(2): 107-115.
18. Corrigan OP. Personalized medicine in a consumer age. Curr Pharmacogenomics Person Med 2011; 9(3) (in press).
19. WHO. Background on the global strategy and plan of action on public health, innovation and intellectual property. Available from: http://www.who.int/phi/implementation/phi_globstat_action/en/index.html [Accessed June 29, 2011].
20. Gostin L. Transforming global health through broadly imagined global health governance. McGill Journal of Law and Health 2010; 4(1): 3-13.
21. Oxfam Australia. Gender equality. Available from: http://www.oxfam.org.au/explore/gender-equality [Accessed June 29, 2011].
22. Murray CJ, Kulkarni SC, Michaud C, et al. Eight Americas: investigating mortality disparities across races, counties, and racecounties in the United States. PLoS Med 2006; 3(9): e260.
23. Kickbusch I. Health in all policies: where to from here? Health Promotion International 2010; 25(3): 261-264.
24. Brice P. WHO grand challenges in genomics for developing countries. Public Health Genomics Foundation Newsletter 8 June 2011. Available from: http://www.phgfoundation.org/news/8728/[Accessed June 29, 2011].
25. World Health Organization. Maximizing Positive Synergies Collaborative Group. An assessment of interactions between global health initiatives and country health systems. Lancet 2009; 373: 2137-2169.
26. Lehman EM, Wilson ML. Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality. J Viral Hepat 2009; 16(9): 650-658.
27. Kamal SM, Ahmed A, Mahmoud S, et al. Enhanced efficacy of pegylated interferon alpha-2a over pegylated interferon and ribavirin in chronic hepatitis C genotype 4A randomized trial and quality of life analysis. Liver Int 2011; 31(3): 401-411.
28. Kamal SM, Turner B, He Q, et al. Progression of fibrosis in hepatitis C with and without schistosomiasis: correlation with serum markers of fibrosis. Hepatology 2006; 43(4): 771-779.
29. Moore JP. Coreceptors-implications for HIV pathogenesis and therapy. Science 1997; 276(5309): 51-52.
30. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene. Nature 1996; 382(6593): 722-725.
31. Parra J, Portilla J, Pulido F, et al. Clinical Utility of Maraviroc. Clin Drug Investig 2011; May 20 [Epub ahead of print].
32. Othman EE, Al-Hendy A. Molecular genetics and racial disparities of uterine leiomyomas. Best Pract Res Clin Obstet Gynaecol 2008; 22(4): 589-601.
33. Dalal S, Holmes MD, Ramesar RS. Advancing public health genomics in Africa through prospective cohort studies. J Epidemiol Community Health 2010; 64(7): 585-586.
34. Abdelhak S, Adebamowo C, Adeyemo A, et al. Harnessing genomic technologies toward improving health in Africa: opportunities and challenges. Available from: http://h3africa.org/h3africa_whitepaper.pdf [Accessed June 25, 2011].
35. Mgone C, Volmink J, Coles D, et al. Linking research and development to strengthen health systems in Africa. Trop Med Int Health 2010; 15(12): 1404-1406.
36. The New Partnership for Africa's Development (NEPAD). Available from: http://www.nepad.org/ [Accessed on June 29, 2011].
37. Fenech MF, El-Sohemy A, Cahill L, et al. Nutrigenetics and nutrigenomics: viewpoints on current status and applications in nutrition research and dietetics practice. J Nutrigenet Nutrigenom 2011; 4(2): 69-89.
38. Mbikay M, Mayne J, Seidah NG, et al. Of PCSK9, cholesterol homeostasis and parasitic infections: possible survival benefits of loss-of-function PCSK9 genetic polymorphisms. Med Hypotheses 2007; 69(5): 1010-1017.
39. Gasmelseed N, Elsir AA, Deblasio P, et al. Sub-Saharan Centralized Biorepository for genetic and genomic research. Sci Total Environ. 2011 Feb 7 [Epub ahead of print].
40. Sirugo G, Schim Van Der Loeff M, Sam O, et al. A national DNA bank in the Gambia, West Africa and genomic research in developing countries. Nat Gen 2004; 36(8): 785-786.
41. Matimba A, Oluka MN, Ebeshi BU, et al. Establishment of a biobank and pharmacogenetics database of African populations. Eur J Hum Gen 2008; 16(7): 780-783.
42. Behar DM, Yunusbayev B, Metspalu M, et al. The genome-wide structure of the Jewish people. Nature 2010; 466(7303): 238-242.
43. Ndimba BK, Thomas LA. Proteomics in South Africa: current status, challenges and prospects. Biotechnol J 2008; 3(11): 1368-1374.
44. Ray S, Reddy PJ, Jain R, et al. Proteomic technologies for the identification of disease biomarkers in serum: Advances and challenges ahead. Proteomics 2011; 11(11): 2139-2161.
45. Schofield PN, Eppig J, Huala E, et al. Sustaining the data and bioresource commons. Science 2010; 330(6004): 592-593.
46. Duley L, Hofmeyr J, Carroli G, et al. Perinatal research in developing countries - Is it possible? Seminars in Fetal & Neonatal Medicine 2006; 11: 89-96.
47. Pang T. Global health governance: a cart pulled by too many horses? Singapore: Centre on Asia and Globalization, National University of Singapore, 2010. Available from: http://www.youtube.com/watch?v=T7GTvTPtEU4 [Accessed June 29, 2011].
48. Marmot M. BMA presidency acceptance speech: fighting the alligators of health inequalities. BMJ 2010; 341: c3617.
49. WHO. WHO Definition of Health from Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference. New York 1946. Available from: http://apps.who.int/gb/bd/PDF/bd47/EN/constitution-en.pdf [Accessed June 29, 2011].
50. Jasanoff S. Genome-sequencing anniversary. A living constitution. Science 2011; 331(6019): 872.
51. Knoppers BM, Harris JR, Burton PR, et al. From genomic databases to translation: a call to action. J Med Ethics 2011; May 26 [Epub ahead of print].
52. Hudson T. Genome-sequencing anniversary. Genomics and clinical relevance. Science 2011; 331(6017): 547.
53. Taleb NN. The Black Swan: The Impact of the Highly Improbable, 2nd edition. New York: Random House, 2010.
54. European Commission (2007) EUR 22700 - Science & Governance - Taking European knowledge society seriously. Luxembourg: Office for Official Publications of the European Communities. Available from: http://ec.europa.eu/research/sciencesociety/document_library/pdf_06/european-knowledge-society_en.pdf [Accessed June 29, 2011].